PULMONX CORPORATION Write off of Deferred Debt Issuance Cost
PULMONX CORPORATION (LUNG) reported Write off of Deferred Debt Issuance Cost of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:WriteOffOfDeferredDebtIssuanceCost · last filed 2022-03-01
- PULMONX CORPORATION write off of deferred debt issuance cost for the quarter ending 2021-12-31 was $0.00.
- PULMONX CORPORATION write off of deferred debt issuance cost for the quarter ending 2021-09-30 was $0.00.
- PULMONX CORPORATION write off of deferred debt issuance cost for the quarter ending 2020-12-31 was $0.00.
- PULMONX CORPORATION write off of deferred debt issuance cost for the quarter ending 2020-09-30 was $0.00.
- PULMONX CORPORATION write off of deferred debt issuance cost for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- PULMONX CORPORATION write off of deferred debt issuance cost for fiscal 2020 was $3.03M.
- PULMONX CORPORATION write off of deferred debt issuance cost for fiscal 2019 was $0.00.
- PULMONX CORPORATION write off of deferred debt issuance cost for fiscal 2018 was $0.00.
| Period end | Write off of Deferred Debt Issuance Cost 3 month | Write off of Deferred Debt Issuance Cost 6 month | Write off of Deferred Debt Issuance Cost 9 month | Write off of Deferred Debt Issuance Cost 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-10 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $3.03M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $3.03M 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $3.03M 10-Q · filed 2021-08-10 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $0.00 10-K · filed 2021-03-15 | ||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-13 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |